{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009878","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.733938+00:00","generated_at":"2026-05-16T10:47:36.195059+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Inogen prelim Q4 rev ~$82M (+2% YoY); FY25 rev ~$349M (+4%); order delays into H1 2026","bullets":["Q4 2025 preliminary revenue ~$82M, up ~2% YoY; full-year 2025 ~$349M, up ~4% YoY.","Company expects to achieve positive Adjusted EBITDA for full-year 2025.","Shift in timing of a few large customer orders from Q4 2025 to H1 2026 caused disappointment.","Full-year highlights: launches of Voxi 5 concentrator and Aurora Masks in U.S.; revenue growth and progress toward profitability.","Full Q4/FY2025 results and 2026 guidance to be announced on February 24, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009878","json":"https://secwatch.observer/filing/0001193125-26-009878.json","markdown":"https://secwatch.observer/filing/0001193125-26-009878.md","text":"https://secwatch.observer/filing/0001193125-26-009878.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000119312526009878/0001193125-26-009878-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000119312526009878/ingn-20260112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:47:36.195059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}